Necesidades de Reingreso Dentro de una Población con Trastornos Concurrentes de Uso de Opioides y de Salud Mental en Cárceles de Massachusetts, EEUU: Parte de un Plan para Abordar la Epidemia de Opioides


  • Camilo University of Massachusetts, Medical School
  • Paige M. Shaffer University of Massachusetts Chan Medical School
  • Ayorkor Gaba University of Massachusetts Chan Medical School
  • Dara Drawbridge University of Massachusetts Chan Medical School
  • David Smelson University of Massachusetts Chan Medical School


Palabras clave:

Adicción, Justicia Criminal, Salud Mental, Trastornos Concurrentes, Trastorno por Consumo de Opioides


Introducción. Estudios demuestran que el período después de que un individuo con desorden de uso de opioides sale de la cárcel es un período vulnerable. Poco se sabe sobre cuáles son las necesidades para personas que salen de la cárcel y tienen desórdenes concurrentes de salud mental y uso de opioides (COD). Objetivos. Describir las necesidades que presentan las personas con COD dentro de las dos semanas después de ser liberados de la cárcel. Metodología. Data de 155 individuos con COD fue recolectada dentro de las dos semanas posteriores a la liberación en 9 cárceles en Massachusetts. Se hicieron análisis univariados para determinar las necesidades. Resultados. La mayoría de los participantes eran hombres (78.7%), blancos (64.5%), y no hispanos (75.5%). Las necesidades más relevantes eran empleo (88.4% estaban desempleados), prevención de uso de opioides (67.7% dijeron haber tenido una sobredosis no mortal), salud mental (los participantes reportaron ansiedad o tensión un promedio de 8.9 días en los últimos 30 días) y apoyo sobre trauma (71.6% reportaron por lo menos una experiencia traumática en la vida). Conclusiones. Individuos con COD que están reingresando a sus comunidades presentan necesidades críticas que deben ser tratadas de forma rápida.


Agencia Española de Medicamentos y Productos Sanitarios. 2021. Utilización de medicamentos opioids en España.

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.).

Andrews, D. A., & Bonta, J. (2010). The psychology of criminal conduct. New Providence, NJ: Anderson.

Baillargeon, J., Hoge, S. K., & Penn, J. V. (2010). Addressing the challenge of community reentry among released inmates with serious mental illness. American journal of community psychology, 46(3-4), 361-375.

Baranyi, G., Scholl, C., Fazel, S., Patel, V., Priebe, S., & Mundt, A. P. (2019). Severe mental illness and substance use disorders in prisoners in low-income and middle-income countries: a systematic review and meta-analysis of prevalence studies. The Lancet Global Health, 7(4), e461-e471.

Binswanger, I. A., Blatchford, P. J., Mueller, S. R., & Stern, M. F. (2013). Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009. Annals of internal medicine, 159(9), 592-600.

Binswanger, I. A., Stern, M. F., Deyo, R. A., Heagerty, P. J., Cheadle, A., Elmore, J. G., & Koepsell, T. D. (2007). Release from prison—a high risk of death for former inmates. New England Journal of Medicine, 356(2), 157-165.

Bronson, J., Stroop, J., Zimmer, S., & Berzofsky, M. (2017). Drug use, dependence, and abuse among state prisoners and jail inmates, 2007–2009. Washington, DC: United States Department of Justice, Office of Juvenile Justice and Delinquency Prevention.

Cheatle, M. D. (2011). Depression, chronic pain, and suicide by overdose: On the edge. Pain medicine, 12(2), S43-S48.

Cloyes, K. G., Wong, B., Latimer, S., & Abarca, J. (2010). Time to prison return for offenders with serious mental illness released from prison: A survival analysis. Criminal Justice and Behavior, 37(2), 175-187.

Di Lorenzo, R., Galliani, A., Guicciardi, A., Landi, G., & Ferri, P. (2014). A retrospective analysis focusing on a group of patients with dual diagnosis treated by both mental health and substance use services. Neuropsychiatric Disease and Treatment, 10, 1479.

Dydyk, A. M., Jain, N. K., & Gupta, M. (2020). Opioid Use Disorder. StatPearls Internet.

Flynn, P. M., & Brown, B. S. (2008). Co-occurring disorders in substance abuse treatment: Issues and prospects. Journal of substance abuse treatment, 34(1), 36-47.

Gicquelais, R. E., Jannausch, M., Bohnert, A. S., Thomas, L., Sen, S., & Fernandez, A. C. (2020). Links between suicidal intent, polysubstance use, and medical treatment after non-fatal opioid overdose. Drug and alcohol dependence, 212, 108041.

Harris, K. N., & Jenkins, J. (2019). Diverted opportunities: gaps in drug treatment for justice system-involved populations in Harris County, Texas.

Hedegaard, H., Miniño, A. M., & Warner, M. (2020, January). Increase in suicide mortality in the United States, 1999–2018.

Hooker, S. A., Sherman, M. D., Lonergan-Cullum, M., Sattler, A., Liese, B. S., Justesen, K., Nissly, T., & Levy, R. (2020). Mental health and psychosocial needs of patients being treated for opioid use disorder in a primary care residency clinic. Journal of Primary Care & Community Health, 11, 1-8.

Jaffe, A., Du, J., Huang, D., & Hser, Y. I. (2012). Drug-abusing offenders with comorbid mental disorders: Problem severity, treatment participation, and recidivism. Journal of substance abuse treatment, 43(2), 244-250

Kerr, T., Fairbairn, N., Tyndall, M., Marsh, D., Li, K., Montaner, J., & Wood, E. (2007). Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug and alcohol dependence, 87(1), 39-45.

Killeen, T.K., Back, S.E. & Brady, K.T. (2015) Implementation of integrated therapies for comorbid post-traumatic stress disorder and substance use disorders in community substance abuse treatment programs. Drug Alcohol Review, 34(3), 234-241.

Kleck, G., & Jackson, D. (2016). What kind of joblessness affects crime? A national Case–Control study of serious property crime. Journal of quantitative criminology, 32(4), 489-513.

Krausz, R. M., Westenberg, J. N., & Ziafat, K. (2021). The opioid overdose crisis as a global health challenge. Current Opinion in Psychiatry, 34(4), 405-412.

Lee, J. D., Friedmann, P. D., Kinlock, T. W., Nunes, E. V., Boney, T. Y., Hoskinson Jr, R. A., Wilson, D., McDonald R., Rotrosen, J., Gourevitch, M. N., Gordon, M., Fishman, M., Chen, D. T., Bonnie, R. J., Cornish, J. W., Murphy, S. M., & O’Brien, C. P. (2016). Extended-release naltrexone to prevent opioid relapse in criminal justice offenders. New England journal of medicine, 374(13), 1232-1242.

Leece, P., Chen, C., Manson, H., Orkin, A. M., Schwartz, B., Juurlink, D. N., & Gomes, T. (2020). One- year mortality after emergency department visit for nonfatal opioid poisoning: a population-based analysis. Annals of emergency medicine, 75(1), 20-28.

Lenz, A. S., Henesy, R. & Callendar, A. (2016) Effectiveness of seeking safety for cooccurring posttraumatic stress disorder and substance use. Journal of Counseling and Development, 94, 51-61

Lyden, J., & Binswanger, I. A. (2019). The United States opioid epidemic. In Seminars in perinatology , 43(3), 123-131.

Malta, M., Varatharajan, T., Russell, C., Pang, M., Bonato, S., & Fischer, B. (2019). Opioid-related treatment, interventions, and outcomes among incarcerated persons: a systematic review. PLoS medicine, 16(12), e1003002.

Peters, R. H., Wexler, H. K., & Lurigio, A. J. (2015). Co-occurring substance use and mental disorders in the criminal justice system: A new frontier of clinical practice and research. Psychiatric Rehabilitation Journal, 38(1), 1-6.

Peterson, J. K., Skeem, J., Kennealy, P., Bray, B., & Zvonkovic, A. (2014). How often and how consistently do symptoms directly precede criminal behavior among offenders with mental illness? Law and human behavior, 38(5), 439.

Pettersen, H., Landheim, A., Skeie, I., Biong, S., Brodahl, M., Oute, J., & Davidson, L. (2019). How social relationships influence substance use disorder recovery: a collaborative narrative study. Substance abuse: research and treatment, 13, 1178221819833379.

Pinals, D. A., Smelson, D. A., Sawh, L., Harter, J., & Ziedonis, D. (2014). The MISSION-Criminal Justice Treatment Manual. Worcester, University of Massachusetts Medical School.

Redcross, C., Millenky, M., Rudd, T., & Levshin, V. (2011). More than a job: Final results from the evaluation of the Center for Employment Opportunities (CEO) transitional jobs program. OPRE Report, 18.

SAMHSA. (2015). CSAT GPRA Modernization Act Data Collection Tools.

SAMHSA. (2018). Key substance use and mental health indicators in the United States: Results from the 2017 National Survey on Drug Use and Health (HHS Publication No. SMA 18-5068, NSDUH Series H-53). Rockville, MD: Center for Behavioral Health Statistics and Quality. Substance Abuse and Mental Health Services Administration. https://www. samhsa. gov/data.

SAMHSA. (2019). 2018 National Survey on Drug Use and Health: Methodological summary and definitions. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration.

Semenza, D. C., & Link, N. W. (2019). How does reentry get under the skin? Cumulative reintegration barriers and health in a sample of recently incarcerated men. Social Science & Medicine, 243, 112618.

Shaffer, P. M., Posada Rodriguez, C., Gaba, A., Byrne, T., Casey, S. C., Harter, J., & Smelson, D. (2021). Engaging vulnerable populations in drug treatment court: Six month outcomes from a co-occurring disorder wraparound intervention. International Journal of Law and Psychiatry, 76, 101700.

Somer, E. (2019). Trauma, dissociation, and opiate use disorder. Current Addiction Reports, 6(1), 15-20.

Strang, J., Volkow, N. D., Degenhardt, L., Hickman, M., Johnson, K., Koob, G. F., Marshall, B. D. L., Tyndall, M. & Walsh, S. L. (2020). Opioid use disorder. Nature Reviews Disease Primers, 6(1), 1-28.

Sulley, S., & Ndanga, M. (2020). Inpatient Opioid Use Disorder and Social Determinants of Health: A Nationwide Analysis of the National Inpatient Sample (2012-2014 and 2016-2017). Cureus, 12(11).

Taxman, F. S., Pattavina, A., Caudy, M. S., Byrne, J., & Durso, J. (2013). The empirical basis for the RNR model with an updated RNR conceptual framework. In Simulation strategies to reduce recidivism (pp. 73-111). Springer, New York, NY.

Vivolo-Kantor, A. M., Hoots, B. E., Scholl, L., Pickens, C., Roehler, D. R., Board, A., Mustaquim, D., Smith, H., Snodgrass, S. & Liu, S. (2020). Nonfatal Drug Overdoses Treated in Emergency Departments—United States, 2016–2017. Morbidity and Mortality Weekly Report, 69(13), 371.

Winkelman, T. N., Chang, V. W., & Binswanger, I. A. (2018). Health, polysubstance use, and criminal justice involvement among adults with varying levels of opioid use. JAMA Network Open, 1(3), e180558-e180558.

Winter, R. J., Stoove, M., Degenhardt, L., Hellard, M. E., Spelman, T., Jenkinson, R., ... & Kinner, S. A. (2015). Incidence and predictors of non-fatal drug overdose after release from prison among people who inject drugs in Queensland, Australia. Drug and alcohol dependence, 153, 43-49.

Wolff, N., Huening, J., Shi, J., & Frueh, B. C. (2013). Screening for and treating PTSD and substance abuse disorders among incarcerated men. New Brunswick, NJ: Center for Behavioral Health Services & Criminal Justice Research.

Wooditch, A., Tang, L. L., & Taxman, F. S. (2014). Which criminogenic need changes are most important in promoting desistance from crime and substance use? Criminal justice and Behavior, 41(3), 276-299.

Zibbell, J., Howard, J., Clarke, S., Ferrell, A., & Karon, S. (2019). Non-Fatal Opioid Overdose and Associated Health Outcomes: Final Summary Report. Office of the Assistant Secretary for Planning and Evaluation.




Cómo citar

Posada Rodríguez, C., Shaffer, P. M., Gaba, A., Drawbridge, D., & Smelson, D. (2022). Necesidades de Reingreso Dentro de una Población con Trastornos Concurrentes de Uso de Opioides y de Salud Mental en Cárceles de Massachusetts, EEUU: Parte de un Plan para Abordar la Epidemia de Opioides. Health and Addictions/Salud Y Drogas, 22(2), 244–254.



Artículos. Articles